List of mifepristone patents

Patents where

Current Assignee

Industry

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11327083 Treatment and differential diagnosis of Cushing's disease and ectopic Cushing's syndrome	Patent 11327083 was granted and assigned to Corcept Therapeutics on May, 2022 by the United States Patent and Trademark Office.	Corcept Therapeutics	Corcept Therapeutics	United States Patent and Trademark Office	11327083	May 10, 2022
‌ US Patent 11464764 Pharmaceutical formulations containing relacorilant, a heteroaryl-ketone fused azadecalin compound	Patent 11464764 was granted and assigned to Corcept Therapeutics on October, 2022 by the United States Patent and Trademark Office.	Corcept Therapeutics	Corcept Therapeutics	United States Patent and Trademark Office	11464764	October 11, 2022
‌ US Patent 9996672 Systems and methods of treatment using intervention and tasking determination	Patent 9996672 was granted and assigned to Corcept Therapeutics on June, 2018 by the United States Patent and Trademark Office.	Corcept Therapeutics	Corcept Therapeutics	United States Patent and Trademark Office	9996672	June 12, 2018
‌ US Patent 10117852 Glucocorticoid receptor modulators to treat pancreatic cancer	Patent 10117852 was granted and assigned to Corcept Therapeutics on November, 2018 by the United States Patent and Trademark Office.	Corcept Therapeutics	Corcept Therapeutics	United States Patent and Trademark Office	10117852	November 6, 2018
‌ US Patent 10940274 Nasal spray assembly	Patent 10940274 was granted and assigned to Cipla on March, 2021 by the United States Patent and Trademark Office.	Cipla	Cipla	United States Patent and Trademark Office	10940274	March 9, 2021
‌ US Patent 10345602 Microdisplay based immersive headset	Patent 10345602 was granted and assigned to Sun Pharmaceutical on July, 2019 by the United States Patent and Trademark Office.	EMagin	Sun Pharmaceutical	United States Patent and Trademark Office	10345602	July 9, 2019
‌ US Patent 10213414 Glucocorticoid receptor modulators to treat pancreatic cancer	Patent 10213414 was granted and assigned to Corcept Therapeutics on February, 2019 by the United States Patent and Trademark Office.	Corcept Therapeutics	Corcept Therapeutics	United States Patent and Trademark Office	10213414	February 26, 2019
‌ US Patent 7482471 Process for preparation of 1-[9H-carbazol-4-yloxy]-3-[{2-(2-(-methoxy)phenoxy)-ethyl}-amino]-propan-2-ol	Patent 7482471 was granted and assigned to Sun Pharmaceutical on January, 2009 by the United States Patent and Trademark Office.		Sun Pharmaceutical	United States Patent and Trademark Office	7482471	January 27, 2009
‌ US Patent 11058670 Therapeutic uses of relacorilant, a heteroaryl-ketone fused azadecalin glucocorticoid receptor modulator	Patent 11058670 was granted and assigned to Corcept Therapeutics on July, 2021 by the United States Patent and Trademark Office.	Corcept Therapeutics	Corcept Therapeutics	United States Patent and Trademark Office	11058670	July 13, 2021
‌ US Patent 7485421 Polyamide-oligonucleotide derivatives, their preparation and use	Patent 7485421 was granted and assigned to Hoechst GmbH on February, 2009 by the United States Patent and Trademark Office.		Hoechst GmbH	United States Patent and Trademark Office	7485421	February 3, 2009
‌ US Patent 8006695 Inhaler	Patent 8006695 was granted and assigned to Cipla on August, 2011 by the United States Patent and Trademark Office.		Cipla	United States Patent and Trademark Office	8006695	August 30, 2011
‌ US Patent 11504345 Extended release liquid compositions of metformin	Patent 11504345 was granted and assigned to Sun Pharmaceutical on November, 2022 by the United States Patent and Trademark Office.		Sun Pharmaceutical	United States Patent and Trademark Office	11504345	November 22, 2022
‌ US Patent 11523996 Extended release liquid compositions of metformin	Patent 11523996 was granted and assigned to Sun Pharmaceutical on December, 2022 by the United States Patent and Trademark Office.		Sun Pharmaceutical	United States Patent and Trademark Office	11523996	December 13, 2022
‌ US Patent 11202784 Use of glucocorticoid receptor antagonists in combination with glucocorticoids to treat adrenal insufficiency	Patent 11202784 was granted and assigned to Corcept Therapeutics on December, 2021 by the United States Patent and Trademark Office.	Corcept Therapeutics	Corcept Therapeutics	United States Patent and Trademark Office	11202784	December 21, 2021
‌ US Patent 11510878 Extended release multiparticulates of ranolazine	Patent 11510878 was granted and assigned to Sun Pharmaceutical on November, 2022 by the United States Patent and Trademark Office.	Sun Pharmaceutical	Sun Pharmaceutical	United States Patent and Trademark Office	11510878	November 29, 2022
‌ US Patent 9829495 Method for differentially diagnosing ACTH-dependent Cushing's syndrome	Patent 9829495 was granted and assigned to Corcept Therapeutics on November, 2017 by the United States Patent and Trademark Office.	Corcept Therapeutics	Corcept Therapeutics	United States Patent and Trademark Office	9829495	November 28, 2017
‌ US Patent 10568880 Glucocorticoid receptor modulators to treat cervical cancer	Patent 10568880 was granted and assigned to Corcept Therapeutics on February, 2020 by the United States Patent and Trademark Office.	Corcept Therapeutics	Corcept Therapeutics	United States Patent and Trademark Office	10568880	February 25, 2020
‌ US Patent 7638627 Process of preparing imatinib and imatinib prepared thereby	Patent 7638627 was granted and assigned to Cipla on December, 2009 by the United States Patent and Trademark Office.		Cipla	United States Patent and Trademark Office	7638627	December 29, 2009
‌ US Patent 11610666 Systems and methods of managing treatment of a chronic condition by symptom tracking	Patent 11610666 was granted and assigned to Corcept Therapeutics on March, 2023 by the United States Patent and Trademark Office.	Corcept Therapeutics	Corcept Therapeutics	United States Patent and Trademark Office	11610666	March 21, 2023
‌ US Patent 9622979 Multilayered dosage form	Patent 9622979 was granted and assigned to Sun Pharmaceutical on April, 2017 by the United States Patent and Trademark Office.		Sun Pharmaceutical	United States Patent and Trademark Office	9622979	April 18, 2017
‌ US Patent 7208613 Synthesis of s-fluoromethyl 6α,9α-difluoro-11β-hydroxy-16α-methyl-17α-propionyloxy-3-oxoandrosta-1,4-diene-17β-carbothioate	Patent 7208613 was granted and assigned to Sun Pharmaceutical on April, 2007 by the United States Patent and Trademark Office.		Sun Pharmaceutical	United States Patent and Trademark Office	7208613	April 24, 2007
‌ US Patent 10898478 Glucocorticoid receptor modulators to treat cervical cancer	Patent 10898478 was granted and assigned to Corcept Therapeutics on January, 2021 by the United States Patent and Trademark Office.	Corcept Therapeutics	Corcept Therapeutics	United States Patent and Trademark Office	10898478	January 26, 2021
‌ US Patent 10413540 Glucocorticoid receptor modulators to treat cervical cancer	Patent 10413540 was granted and assigned to Corcept Therapeutics on September, 2019 by the United States Patent and Trademark Office.	Corcept Therapeutics	Corcept Therapeutics	United States Patent and Trademark Office	10413540	September 17, 2019
‌ US Patent 11447535 GLP-1 analogues	Patent 11447535 was granted and assigned to Sun Pharmaceutical on September, 2022 by the United States Patent and Trademark Office.		Sun Pharmaceutical	United States Patent and Trademark Office	11447535	September 20, 2022
‌ US Patent 11464425 Flow sensing arrangement for spirometer and method thereof		Cipla	Cipla	United States Patent and Trademark Office	11464425	October 11, 2022

...

Results per page:

373 results

0 selected

373 results

0 selected